IGC Pharma (IGC) Receivables - Net (2011 - 2026)
IGC Pharma's Receivables - Net came in at $37,000 for Q4 2026, up 8.8% from $34,000 a year earlier and up 208.3% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Receivables - Net (2011 - 2026) Analysis & Trends
Going back to Q4 2011, IGC Pharma's Receivables - Net data covers 61 quarters.
- Receivables - Net carries a five-year compound annual growth rate of -26.7% (FY2021 to FY2026).
- Going back by year, Receivables - Net was $34,000 in FY2025 (-12.8%), $39,000 in FY2024 (-63.6%), $107,000 in FY2023 (-14.4%) and $125,000 in FY2022 (-28.6%).
- The five-year range for quarterly Receivables - Net is $12,000 (Q3 2026) to $251,000 (Q3 2023).
- Year-over-year, Receivables - Net increased in two of the last eight quarters, with an average decline of 9.7%.
- The fastest year-over-year change in Receivables - Net over five years came in Q1 2026 (growth of 210.7%), and the weakest in Q1 2025 (a decline of 87.6%).
- Business Quant data shows IGC's Receivables - Net at $12,000 (Q3 2026), $41,000 (Q2 2026) and $87,000 (Q1 2026) in the three quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 164,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 162,000.00 |
API Access
IGC Pharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();